News
Implementing animal-free recombinant proteins into stem cell supply chains
Most industries today are under pressure to switch to more ethical and sustainable animal-free alternatives, and now the trend is ...
Rob Nixon joins Qkine as Head of Commercial and Dr Cassie Doherty is appointed to the board
Cambridge, UK 21 July 2020: Qkine – a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative ...
Video: Growth factor purity and its implications for stem cell culture
Presentation by Luana Ferrara, Senior Protein Scientist Video script Slide 1: Introduction Hello! My name is Luana Ferrara and I ...
Qkine secures £1.5M series A funding from leading life science investors
Cambridge, UK 08 June 2020: Qkine – a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative ...
Qkine secures additional £550K to extend development of R&D pipeline and accelerate commercialisation of product portfolio
Cambridge, UK 03 June 2019: Qkine, specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications, has closed ...
Why quality is not just about purity – by Qkine founder Dr Marko Hyvönen
As a structural biologist, one will very quickly realise that protein not only needs to be pure, but it needs ...
So what does the “i” in iteams mean?
Running for over a decade, the iteams programme partners multi-disciplinary teams of PhD students and postdocs with inventors from the ...
Building next generation growth factors for organoid-driven precision medicine: a protein engineering project co-funded by Innovate UK
We were delighted to be awarded Innovate UK funding to address issues of quality and availability of growth factors for ...
Qkine backed by Cambridge Enterprise and a quintet of angels
University of Cambridge spin-out Qkine has closed its seed investment round supported by Cambridge Enterprise, the commercialisation arm of the ...
